NO994640L - Hostestillende midler - Google Patents

Hostestillende midler

Info

Publication number
NO994640L
NO994640L NO994640A NO994640A NO994640L NO 994640 L NO994640 L NO 994640L NO 994640 A NO994640 A NO 994640A NO 994640 A NO994640 A NO 994640A NO 994640 L NO994640 L NO 994640L
Authority
NO
Norway
Prior art keywords
theobromine
additives
salts
solid
active ingredients
Prior art date
Application number
NO994640A
Other languages
English (en)
Norwegian (no)
Other versions
NO994640D0 (no
Inventor
Dezs Korbonits
Peter Arsnyi
Istvsn Jelinek
Endre Mikus
Original Assignee
Dezs Korbonits
Peter Arsnyi
Istvsn Jelinek
Endre Mikus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dezs Korbonits, Peter Arsnyi, Istvsn Jelinek, Endre Mikus filed Critical Dezs Korbonits
Publication of NO994640D0 publication Critical patent/NO994640D0/no
Publication of NO994640L publication Critical patent/NO994640L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
NO994640A 1997-03-26 1999-09-24 Hostestillende midler NO994640L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9700654A HUP9700654A2 (hu) 1997-03-26 1997-03-26 Teobromin tartalmú köhögéscsillapító készítmények
PCT/HU1998/000027 WO1998042322A2 (fr) 1997-03-26 1998-03-20 Compositions antitussives

Publications (2)

Publication Number Publication Date
NO994640D0 NO994640D0 (no) 1999-09-24
NO994640L true NO994640L (no) 1999-09-24

Family

ID=89994918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO994640A NO994640L (no) 1997-03-26 1999-09-24 Hostestillende midler

Country Status (23)

Country Link
US (1) US6348470B1 (fr)
EP (1) EP0969843B1 (fr)
JP (1) JP4450872B2 (fr)
KR (1) KR100420370B1 (fr)
CN (1) CN1251039A (fr)
AT (1) ATE218868T1 (fr)
AU (1) AU6741498A (fr)
BG (1) BG103780A (fr)
BR (1) BR9809057A (fr)
CA (1) CA2284774C (fr)
CZ (1) CZ295801B6 (fr)
DE (1) DE69805983T2 (fr)
DK (1) DK0969843T3 (fr)
EA (1) EA001971B1 (fr)
EE (1) EE9900428A (fr)
ES (1) ES2178188T3 (fr)
HU (1) HUP9700654A2 (fr)
IL (2) IL131811A0 (fr)
NO (1) NO994640L (fr)
PL (1) PL190899B1 (fr)
PT (1) PT969843E (fr)
SK (1) SK285023B6 (fr)
WO (1) WO1998042322A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030032484A (ko) * 2001-10-18 2003-04-26 롯데제과주식회사 발암 억제효능을 갖는 데오브로민
JP2004018512A (ja) * 2002-06-20 2004-01-22 Morinaga & Co Ltd 冷え性改善用組成物および冷え性改善用組成物の製造のためのカカオ豆加工物の使用
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
KR20080009994A (ko) * 2006-07-25 2008-01-30 안국약품 주식회사 기침 치료용 조성물
US7914828B2 (en) * 2008-10-17 2011-03-29 Levine Brian M Combination herbal product to benefit respiratory tract
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0919893D0 (en) 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
US20150005325A1 (en) * 2009-06-16 2015-01-01 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
US20150216869A1 (en) * 2009-06-16 2015-08-06 Biocopea Limited Drug Combinations and Uses in Treating a Coughing Condition
GB0921805D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
GB201014391D0 (en) 2010-08-27 2010-10-13 Biocopea Ltd Drug composition and its use in therapy
GB0919889D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB0921803D0 (en) 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
AU2015201845B2 (en) * 2009-11-13 2015-11-05 Infirst Healthcare Limited Drug combination with theobromine and its use in therapy
US8361519B2 (en) 2010-11-18 2013-01-29 Aadvantics Pharmaceuticals, Inc. Combination herbal product to benefit respiratory tract in people exposed to smoke
NL1040474C2 (en) 2013-10-31 2015-05-04 Veramed B V Nasal compositions stimulating ciliary activity.
ES2552706B1 (es) * 2014-05-29 2016-09-13 Universitat De Les Illes Balears La teobromina y sus derivados para el tratamiento o prevenciónde la litiasis renal
KR20160126217A (ko) 2015-04-23 2016-11-02 주식회사 진명 에프 엠 씨 용기 투입장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1113122B (it) * 1978-04-06 1986-01-20 Abc Ist Biolog Chem Spa Composizione farmaceutica ad attivita' antibrocospastica e antitosse
FR2531339A1 (fr) 1982-08-04 1984-02-10 Dietlin Francois Nouveau procede d'obtention de formes pharmaceutiques a liberation programmee
HU197574B (en) 1986-10-09 1989-04-28 Chinoin Gyogyszer Es Vegyeszet Process for production of derivatives of 3,7-dihydro-3-methil-7-//1,2,4-oxadiasole/-3-il/alkylenil/-1h-purin-2,6-dion and medical compositions containing these substances
GB2201591B (en) 1987-03-02 1990-11-14 Ricerfarma Srl Analgesic antipyretic and anti-inflammatory compositions.
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
DK339289D0 (da) * 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
JPH09502201A (ja) 1993-09-07 1997-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー プロピオン酸非ステロイド系抗炎症剤のアミノ酸塩とうっ血除去剤、去痰剤、抗ヒスタミン剤及び鎮咳剤のうち少くとも１種を含有した組成物
US5560913A (en) 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
JPH11510168A (ja) 1995-07-28 1999-09-07 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸障害を処理するための鎮痛剤及び抗ヒスタミン剤を含有する組成物及び方法

Also Published As

Publication number Publication date
BR9809057A (pt) 2000-08-01
DE69805983T2 (de) 2003-01-30
CN1251039A (zh) 2000-04-19
NO994640D0 (no) 1999-09-24
EA001971B1 (ru) 2001-10-22
DE69805983D1 (de) 2002-07-18
CA2284774A1 (fr) 1998-10-01
WO1998042322A3 (fr) 1998-12-17
EE9900428A (et) 2000-04-17
US6348470B1 (en) 2002-02-19
KR100420370B1 (ko) 2004-03-03
ES2178188T3 (es) 2002-12-16
DK0969843T3 (da) 2002-10-07
PL335979A1 (en) 2000-06-05
JP2001518928A (ja) 2001-10-16
IL131811A0 (en) 2001-03-19
PL190899B1 (pl) 2006-02-28
KR20010005642A (ko) 2001-01-15
SK127399A3 (en) 2000-09-12
CA2284774C (fr) 2005-12-06
PT969843E (pt) 2002-10-31
AU6741498A (en) 1998-10-20
WO1998042322A2 (fr) 1998-10-01
HUP9700654A2 (hu) 1999-09-28
HU9700654D0 (en) 1997-05-28
JP4450872B2 (ja) 2010-04-14
BG103780A (en) 2001-04-30
EA199900876A1 (ru) 2000-04-24
SK285023B6 (sk) 2006-04-06
CZ339199A3 (cs) 2000-04-12
ATE218868T1 (de) 2002-06-15
IL131811A (en) 2006-06-11
EP0969843B1 (fr) 2002-06-12
EP0969843A2 (fr) 2000-01-12
CZ295801B6 (cs) 2005-11-16

Similar Documents

Publication Publication Date Title
NO994640L (no) Hostestillende midler
DE9190171U1 (fr)
AU2147992A (en) Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
NO873589D0 (no) Blanding som inneholder ldopa.
NO974693L (no) Farmasöytisk preparat inneholdende N-klorfenylkarbamater, N-klorfenyltiokarbamater og N-fosfonoglycin-derivater for å inhibere vekst av cancer og virus i pattedyr
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
NO164904C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive griseolsyrederivater.
NO890046D0 (no) Disubstituerte pyridiner.
NO932722L (no) Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
SE8403659L (sv) Synergistiska farmaceutiska kompositioner
Philpott et al. Treatment of the Schoenlein-Henoch syndrome with adrenocorticotrophic hormone (ACTH) and cortisone
MY135972A (en) Egg anti-inflammatory composition and method of treating and preventing inflammation
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
KR900016156A (ko) 퀴녹살린 유도체 및 궤양치료제
GB1507643A (en) 4-(5-nitro-2-furyl)quinaldinic acid n-oxide and its use in the treatment of bovine mastitis
NO980127L (no) Anvendelse av ipriflavon for å redusere antall CD8+ celler
JPS5699420A (en) Immune reactivator
SE7703625L (sv) Forfarande for beredning av ensilage
CO4750838A1 (es) Metodo para el tratamiento de reacciones inflamatorias adversas y la composicion antiinflamatoria administrada

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application